+ Follow QUEEN MARY HOSPITAL HONG KONG Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 300282
[Title] => New hepa B treatment outdoes standard care
[Summary] => A recent study shows that peginterferon alfa 2-a, a new hepatitis B treatment, provides a significantly greater proportion of patients with lasting remission compared to lamivudine, the current standard of care.
A study was conducted among patients with HbeAG positive hepatitis B, the subtype of the disease which affects majority of hepatitis B patients worldwide.
[DatePublished] => 2005-10-06 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
QUEEN MARY HOSPITAL HONG KONG
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 300282
[Title] => New hepa B treatment outdoes standard care
[Summary] => A recent study shows that peginterferon alfa 2-a, a new hepatitis B treatment, provides a significantly greater proportion of patients with lasting remission compared to lamivudine, the current standard of care.
A study was conducted among patients with HbeAG positive hepatitis B, the subtype of the disease which affects majority of hepatitis B patients worldwide.
[DatePublished] => 2005-10-06 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
abtest
October 6, 2005 - 12:00am